Loratadine during pregnancy and hypospadias [1]

Epidemiology

Volumn 19, Issue 2, 2008, Pages 359-360

  Pedersen, Lars ^a   Nørgaard, Mette ^a   Rothman, Kenneth J ^b   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b RTI HEALTH SOLUTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORATADINE;

BIRTH ORDER; DATA BASE; DENMARK; DISEASE ASSOCIATION; DRUG EXPOSURE; GESTATIONAL AGE; HUMAN; HYPOSPADIAS; LETTER; MATERNAL AGE; MATERNAL WELFARE; PREECLAMPSIA; PREGNANCY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT;

ABNORMALITIES, DRUG-INDUCED; ANTI-ALLERGIC AGENTS; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; HYPOSPADIAS; INFANT, NEWBORN; LOGISTIC MODELS; LORATADINE; MALE; PREGNANCY; REGISTRIES; SWEDEN;

EID: 39149083706     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e318162a934     Document Type: Letter

References (5)

1. Källén B, Olausson PO. Monitoring of maternal drug use and infant congenital malformations. Does Loratadine cause hypospadias? Int J Risk Safety Med. 2002;14:115-119.
2. Källén B, Olausson PO. No increased risk of infant hypospadias after maternal use of loratadine in early pregnancy? Int J Med Sci. 2006;3:106-107.
3. Centers for Disease Control and Prevention (CDC). Evaluation of an association between loratadine and hypospadias-United States, 1997-2001. MMWR Morb Mortal Wkly Rep. 2004;53:219-221.
4. Pedersen L, Nørgaard M, Skriver MV, Sørensen HT. Maternal use of loratadine during pregnancy and risk of hypospadias in offspring. Int J Med Sci. 2006;3:21-25.
5. Pedersen L, Nørgaard M, Skriver MV, Olsen J, Sørensen HT. A nested case-control study within the Danish National Birth Cohort. Am J Ther. 2006;13:320-324